Search Results - "Derkach, EV"

Refine Results
  1. 1

    Tofacitinib in Adult Patients with Active Rheumatoid Arthritis: Budget Impact Analysis by Pyadushkina, E, Derkach, EV

    Published in Value in health (01-10-2017)
    “…BACKGROUND: Tofacitinib is a new drug in Russian pharmaceutical market indicated for adult patients with active rheumatoid arthritis (RA) and an inadequate…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Cost-Effectiveness of Vedolizumab for the Treatment of Adult Patients with Moderately-to-Severely Active Ulcerative Colitis in Russia by Pyadushkina, E, Derkach, EV

    Published in Value in health (01-10-2017)
    “…BACKGROUND: Vedolizumab is one of the biologic drugs recommended by current clinical guidelines for the treatment of moderately-to-severely active ulcerative…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    The Impact of Increase in The Proportion of Early Breast Cancer Cases on Costs and Outcomes by Ignatyeva, V, Avxentyeva, M, Derkach, EV, Omelyanovskiy, VV, Boyarskaya, T

    Published in Value in health (01-10-2017)
    “…INTRODUCTION: There is a widespread belief among medical specialists in Russia, that increase in the proportion of breast cancer (BC) cases detected on early…”
    Get full text
    Journal Article
  14. 14

    Cost Of Hospital Treatment For Severe And Moderate-To-Severe Influenza In Russia by Pyadushkina, E, Avxentyeva, M, Derkach, EV, Boyarskaya, T, Ignatyeva, V

    Published in Value in health (01-10-2017)
    “…BACKGROUND: Respiratory viral infection (RVI) both in children and adults is one of the leading causes of hospitalizations in Russia every year. Presently the…”
    Get full text
    Journal Article
  15. 15

    The Cost and Outcomes of Breast Cancer Screening for Women 40-49 Years Old in Russia by Ignatyeva, Derkach, EV, Avxentyeva, M, Omelyanovskiy, VV, Boyarskaya, T

    Published in Value in health (01-10-2017)
    “…INTRODUCTION: In Russia screening for breast cancer (BC) is recommended for women 39-75 years old, though WHO recommends starting BC screening at the age of 50…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    The Economic Burden of Breast Cancer in Russia by Ignatyeva, V, Derkach, EV, Avxentyeva, M, Omelyanovskiy, VV

    Published in Value in health (01-10-2017)
    “…OBJECTIVES: To estimate the annual costs of breast cancer (BC) in Russia. METHODS: We estimated annual direct medical costs (for diagnostics, treatment,…”
    Get full text
    Journal Article
  20. 20